[Efficacy of duphaston treatment in women with endometriosis after reconstructive surgery].

Akusherstvo i ginekologiia · 2003 · vol. 42(4) , pp. 42–6 · PMID:14577368 · W59607154
article OA: closed CC0 ⤵ 8 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-07

This study evaluated 300 women with endometriosis, finding dydrogesterone (Duphaston) to be the most effective post-operative hormonal therapy after reconstructive surgery.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The authors present outcomes of inspection of 300 women suffering from genital endometriosis. Localization and thermocoagulation of endometriosis was performed by diagnostic and operative laparoscopy. After operation women were treated with hormonomodulative therapy. Patients were divided in five groups, depending on prescribed treatment. The authors concluded that the most effective is therapy with progestine dydrogesterone (Duphaston). For comparison there are presented groups of patients without hormonal treatment after operation. The authors recommend hormonomodulative therapy after surgical treatment of endometriosis. Duphaston was indicated as the most preferable drug.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Dydrogesterone Endometriosis Endometriosis Endometriosis Menstrual Cycle Plastic Surgery Procedures Adult Dydrogesterone Female Humans Laparotomy Menstrual Cycle Middle Aged

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (8)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:44.121522+00:00
License: CC0 · commercial use OK